Beyond Next Ventures Inc.
Beyond Next Ventures Inc. is a company.
Financial History
Leadership Team
Key people at Beyond Next Ventures Inc..
Beyond Next Ventures Inc. is a company.
Key people at Beyond Next Ventures Inc..
Beyond Next Ventures Inc. (BNV) is a Tokyo-based venture capital firm founded in 2014, managing over USD 340 million in assets and investing exclusively in seed-stage deep tech startups in Japan and India.[1][4][5] Its core mission is to harness Japanese science and technology by supporting researchers and entrepreneurs to commercialize innovations, building an ecosystem that includes financing, shared labs, business planning, and talent development to create a "beyond next society" addressing global challenges.[1][5] The firm's investment philosophy emphasizes early-stage deep tech with social and environmental impact, partnering from inception through IPOs and M&As, while operating Japan's largest seed acceleration program "BRAVE" and programs like "Innovation Leaders" for corporate talent.[1][4]
BNV focuses on key sectors such as deep tech, climate, healthcare, life sciences, quantum computing, AI, and biotech, with a portfolio exceeding 50 companies including CureApp (digital therapeutics), Yaqumo (quantum computers), and Indian firms like Medibuddy and GigIndia (acquired by PhonePe).[1][2][3][4][5] It significantly impacts the startup ecosystem by bridging academia, corporations, and ventures, accelerating R&D commercialization, and fostering over 2,000 tech specialists.[1][4]
Beyond Next Ventures was incorporated on August 12, 2014, in Tokyo, Japan, under President Tsuyoshi Ito, with a focus on discovering and commercializing outstanding research from universities and large companies.[1][5] Key partners include Akito Arima (Partner, Tokyo), Jay Krishnan (Partner & Head of Investments, India, Bengaluru), and others like Hiroki Mikuni (Manager).[7] From its inception, BNV targeted deep tech in Japan, expanding to India to tap broader innovation pools, managing funds closed as recently as July 2024.[1][2][7]
The firm's evolution reflects a shift toward ecosystem building: starting with investments, it launched incubation support (wet labs, executive matching), acceleration via "BRAVE," and talent programs, achieving certifications for Japanese grants like NEDO and START.[1][4][5] Pivotal moments include growing to USD 340 million AUM, over 50 investments, and recent 2025 deals in GramEye (automated diagnostics) and FinalLayer (AI agents).[3][5]
BNV rides the deep tech wave, capitalizing on Japan's research prowess in biotech, quantum, and AI alongside India's scaling ecosystem for climate and healthcare solutions.[1][2][3][5] Timing is ideal amid global pushes for tech sovereignty, post-pandemic digital health demand, and climate urgency, with Japan's government backing via grants aligning with BNV's model.[1][4] Market forces like rising VC for hard tech (e.g., quantum error correction in Yaqumo) and affordable biotech (GramEye) favor its early bets.[3][5]
The firm influences the ecosystem by de-risking academic spin-outs, enabling cross-border Japan-India flows, and upskilling talent, thus amplifying deep tech's role in solving environmental and health crises beyond traditional software VC.[1][4][5]
BNV is poised to expand its USD 340 million AUM through new funds post-2024 closes, targeting surging deep tech areas like AI agents, quantum, and climate tech amid 2025 investments signaling momentum.[1][5][7] Trends like AI-driven drug discovery, sustainable biotech from waste (AlgaleX), and gig economy tools will shape its path, bolstered by Japan-India synergies and corporate partnerships.[3][5] Its influence may evolve into a dominant Asia deep tech platform, potentially scaling exits and ecosystem programs to rival global players, fulfilling its vision of a science-fueled "next society."[1] This positions BNV as a pivotal enabler for innovators transforming global challenges.
Key people at Beyond Next Ventures Inc..